CFI Trademark

Trademark Overview

On Monday, July 20, 2020, a trademark application was filed for CFI with the United States Patent and Trademark Office. The USPTO has given the CFI trademark a serial number of 90062017. The federal status of this trademark filing is REGISTERED as of Tuesday, January 31, 2023. This trademark is owned by Aphios Corporation. The CFI trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacturing of pharmaceutical agents including blood products and biological products
cfi

General Information

Serial Number90062017
Word MarkCFI
Filing DateMonday, July 20, 2020
Status700 - REGISTERED
Status DateTuesday, January 31, 2023
Registration Number6969539
Registration DateTuesday, January 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 28, 2021

Trademark Statements

Goods and ServicesCustom manufacturing of pharmaceutical agents including blood products and biological products

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, January 12, 2021
Primary Code040
First Use Anywhere DateSaturday, October 23, 1993
First Use In Commerce DateWednesday, January 18, 2012

Trademark Owner History

Party NameAphios Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801
Party NameAphios Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801
Party NameAphios Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoburn, MA 01801

Trademark Events

Event DateEvent Description
Tuesday, January 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 31, 2023REGISTERED-PRINCIPAL REGISTER
Friday, December 30, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 29, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 29, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, December 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 29, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, December 29, 2022SU-EXAMINER'S AMENDMENT WRITTEN
Thursday, June 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 30, 2022NON-FINAL ACTION E-MAILED
Thursday, June 30, 2022SU - NON-FINAL ACTION - WRITTEN
Wednesday, May 25, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, May 12, 2022USE AMENDMENT FILED
Wednesday, May 25, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 12, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, November 23, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 28, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 28, 2021PUBLISHED FOR OPPOSITION
Wednesday, September 8, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 22, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, February 3, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 3, 2021FINAL REFUSAL E-MAILED
Wednesday, February 3, 2021FINAL REFUSAL WRITTEN
Tuesday, January 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 12, 2021NON-FINAL ACTION E-MAILED
Tuesday, January 12, 2021NON-FINAL ACTION WRITTEN
Friday, November 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 6, 2020NON-FINAL ACTION E-MAILED
Friday, November 6, 2020NON-FINAL ACTION WRITTEN
Tuesday, November 3, 2020ASSIGNED TO EXAMINER
Tuesday, August 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 23, 2020NEW APPLICATION ENTERED

Related Keywords

products blood biological including agents manufacturing pharmaceutical custom